PBYI Puma Biotechnology Inc - Common Stock
$9,41
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$4–$10
98% of range
تقييم المحللين
HOLD
6 analysts
السعر المستهدف
$6
P/E (TTM)
15.6
ROE
26.5%
هامش صافي الربح
13.6%
حول Puma Biotechnology Inc - Common Stock نظرة عامة على الشركة من ويكيبيديا
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
اقرأ المزيد
Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.
Creation
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.
Funding for development
In August 2011 Puma licensed two drug candidates from Pfizer: neratinib (PB272) and an analog (PB357) to serve as a backup candidate.
As part of an approximately $60 million financing round in October 2011, Puma entered into a reverse merger with the shell company Innovative Acquisitions Corp., formed in 2007. In April 2012 the company's stock began trading over the counter. In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange.
In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an internal investigation and reported the insider trading to the SEC.
Approval and licensing of neratinib
In March 2016 Puma held a pre-NDA meeting with the FDA in which the FDA raised concerns about the design and conduct of clinical trials that Puma had run and recommended that Puma not file the NDA with that data.
Puma did file the NDA, and in May 2017 an FDA review panel recommended that the FDA approve neratinib but raised concerns that the intended use was too broad and should be limited to people with specific mutations. The FDA's briefing document to the panel had raised concerns about the marginal benefit of the drug and the side effects. In July 2017 the FDA approved neratinib for use in preventing the return of breast cancer after treatment that included trastuzumab and without any need for genetic testing, and with warnings about the risk of severe diarrhea. U.S. sales of neratinib totaled $200.5 million in 2018.
In January 2018 an EMA committee gave a negative review to neratinib. In June 2018 this same EMA committee recommended the approval of neratinib, which received European Commission (EC) approval in September 2018.
In 2019 Puma licensed commercialization rights in Europe and part of Africa to Pierre Fabre for an upfront payment of $60 million and milestone payments that could reach $345 million. Previously, Puma licensed rights in Greater China to CANbrdige Life Sciences, rights in Israel to Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma.
== References ==
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
PBYI لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$9.41
القيمة السوقية
$479M
P/E (TTM)
15.6
ربح السهم (آخر 12 شهرًا)
$0.61
الإيرادات (آخر 12 شهرًا)
$228M
عائد التوزيعات
—
ROE
26.5%
D/E الدين/حقوق الملكية
0.2
نطاق 52 أسبوعًا
$4 – $10
PBYI مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$228M
2017-12-31
→
2025-12-31
ربح السهم
$0.61
2020-12-31
→
2025-12-31
التدفق النقدي الحر
$42M
2016-12-31
→
2025-12-31
الهوامش
13.6%
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
PBYI
متوسط الأقران
P/E (TTM)
15.6
17.4
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
2.1
52.3
P/B (السعر / القيمة الدفترية)
3.7
4.8
EV / EBITDA
10.8
—
Price / FCF (السعر / التدفق النقدي الحر)
11.5
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
PBYI
متوسط الأقران
Operating Margin (هامش التشغيل)
16.3%
—
Net Profit Margin (هامش صافي الربح)
13.6%
-670.1%
ROA (العائد على الأصول)
14.5%
-41.1%
ROE
26.5%
-52.6%
ROIC
21.2%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
PBYI
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
0.2
—
Current Ratio (النسبة الحالية)
2.0
7.7
Quick Ratio (النسبة السريعة)
1.9
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
PBYI
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
-0.91%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
0.05%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
0.29%
—
EPS YoY (ربحية السهم على أساس سنوي)
-1.6%
—
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
2.8%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
PBYI
متوسط الأقران
PBYI توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
بيع
6 محللين
- شراء قوي 0 0,0%
- شراء 0 0,0%
- احتفاظ 3 50,0%
- بيع 1 16,7%
- بيع قوي 2 33,3%
السعر المستهدف لمدة 12 شهرًا
1 محللين · 2026-08-18
منخفض
$6.00
مرتفع
$6.00
السعر المستهدف الوسيط
$6.00
-36,2%
السعر المستهدف المتوسط
$6.00
-36,2%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.07%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.16 | $0.04 | 0.12% |
| 31 مارس، 2026 | $-0.07 | $-0.13 | 0.06% |
| 31 ديسمبر، 2025 | $0.26 | $0.23 | 0.03% |
| 30 سبتمبر، 2025 | $0.17 | $0.05 | 0.12% |
| 30 يونيو، 2025 | $0.12 | $0.10 | 0.02% |
| 31 مارس، 2025 | $0.06 | $-0.02 | 0.08% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Cost of Revenue | $58M | $64M | $63M | $55M | $64M | $39M | $37M | $35M | $6M | |
| R&D Expense | · | · | · | · | $72M | $98M | $133M | $165M | $208M | |
| SG&A Expense | $71M | $80M | $90M | $90M | $116M | $118M | $142M | $146M | $107M | |
| Operating Expenses | $191M | $200M | $203M | $204M | $252M | $256M | $311M | $346M | $320M | |
| Operating Income | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M | |
| Interest Expense | · | · | $13M | $12M | $13M | $14M | $15M | $11M | $720.0K | |
| Interest Income | $4M | $5M | $3M | $813.0K | $160.0K | $489.0K | $3M | $2M | $1M | |
| Other Non-op | $1M | $862.0K | $759.0K | $-28.0K | $292.0K | $367.0K | $128.0K | $-714.0K | $-101.0K | |
| Pretax Income | $36M | $24M | $23M | $457.0K | $-29M | $-60M | $-76M | $-114M | · | |
| Income Tax | $5M | $-6M | $1M | $455.0K | $324.0K | $207.0K | $53.0K | $17.0K | $0 | |
| Net Income | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| EPS (Basic) | $0.62 | $0.62 | $0.46 | $0.00 | $-0.72 | $-1.52 | $-75595.00 | · | · | |
| EPS (Diluted) | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 | $-1.52 | · | · | · | |
| Shares (Basic) | 50,011,485 | 48,648,701 | 47,134,331 | 44,674,501 | 40,638,852 | 39,576,107 | · | · | · | |
| Shares (Diluted) | 50,653,283 | 49,100,433 | 47,550,852 | 44,929,998 | 40,638,852 | 39,576,107 | · | · | · | |
| EBITDA | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M |
الميزانية العمومية 26
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $69M | $85M | $76M | $63M | $85M | $60M | $108M | $82M | |
| Short-term Investments | $68M | $32M | $11M | $5M | $19M | $8M | $52M | $57M | · | |
| Receivables | $54M | $32M | $48M | $40M | $33M | $26M | $29M | $21M | $10M | |
| Inventory | $6M | $9M | $7M | $5M | $7M | $3M | $3M | $3M | $2M | |
| Prepaid Expense | $4M | $6M | $4M | $6M | $9M | $11M | $13M | $12M | $13M | |
| Other Current Assets | $256.0K | $91.0K | $912.0K | $2M | $447.0K | $4M | $323.0K | $2M | · | |
| Current Assets | $163M | $148M | $156M | $134M | $140M | $146M | $166M | $203M | $106M | |
| PP&E (Net) | $187.0K | $515.0K | $855.0K | $1M | $2M | $2M | $3M | $4M | $4M | |
| PP&E (Gross) | $5M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $5M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Intangibles | $41M | $51M | $61M | $71M | $66M | $74M | $40M | $44M | $48M | |
| Total Assets | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Accounts Payable | $5M | $6M | $7M | $6M | $11M | $12M | $19M | $21M | $28M | |
| Accrued Liabilities | $50M | $37M | $53M | $53M | $93M | $61M | $69M | $46M | $31M | |
| Current Liabilities | $81M | $96M | $99M | $77M | $110M | $114M | $91M | $67M | $58M | |
| Capital Leases | $5M | $1M | $7M | $12M | $16M | $20M | $23M | · | · | |
| Other Non-current Liabilities | $0 | $121.0K | $121.0K | · | · | · | · | · | · | |
| Total Liabilities | $86M | $121M | $177M | $200M | $229M | $250M | $217M | $225M | $112M | |
| Long-term Debt | $23M | $68M | $102M | $102M | $102M | $84M | $95M | $152M | $48M | |
| Total Debt | $23M | $67M | $100M | $98M | $97M | $98M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.28B | $-1.31B | $-1.35B | $-1.37B | $-1.37B | $-1.34B | $-1.28B | $-1.20B | $-1.09B | |
| AOCI | $36.0K | $6.0K | $-4.0K | $0 | $-2.0K | $0 | $62.0K | $-12.0K | · | |
| Stockholders' Equity | $130M | $92M | $53M | $22M | $-2M | $-6M | $17M | $34M | $53M | |
| Liabilities + Equity | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Shares Outstanding | 50,408,023 | 49,105,834 | 47,646,787 | 46,345,660 | 41,175,507 | 40,086,387 | 39,203,304 | 38,325,037 | 37,594,851 |
التدفق النقدي 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $12M | $12M | $10M | $11M | $10M | $8M | $7M | $3M | |
| Stock-based Comp | $7M | $8M | $10M | $12M | $33M | $37M | $57M | $87M | $109M | |
| Deferred Tax | $3M | $-7M | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $10M | $10M | $8M | $8M | $8M | $6M | $4M | $4M | $2M | |
| Operating Cash Flow | $42M | $39M | $27M | $-16M | $21M | $773.0K | $22M | $-24M | $-172M | |
| CapEx | $71.0K | $56.0K | $140.0K | $0 | $0 | $46.0K | $306.0K | $439.0K | $431.0K | |
| Investing Cash Flow | $-36M | $-20M | $-19M | $7M | $-11M | $33M | $5M | $-58M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Financing Cash Flow | $-45M | $-34M | $0 | $12M | $-32M | $-10M | $-67M | $108M | $75M | |
| Net Change in Cash | $-40M | $-15M | $8M | $4M | $-22M | $24M | $-40M | $27M | $-113M | |
| Taxes Paid | $1M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $42M | $39M | $27M | $-16M | $21M | · | · | $-25M | $-173M | |
| Levered FCF | · | · | $14M | $-16M | $8M | · | · | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| Net Margin | 13.6% | 13.1% | 9.2% | 0.00% | -11.5% | -26.7% | -27.8% | -45.2% | -1054.6% | |
| Pretax Margin | 15.7% | 10.5% | 9.6% | 0.20% | -11.4% | -26.6% | · | · | · | |
| EBITDA Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| ROA | 14.5% | 13.6% | 9.5% | 0.00% | -12.4% | -25.0% | -30.6% | -53.5% | -139.6% | |
| ROE | 26.5% | 37.1% | 46.8% | 0.01% | 435.8% | 1873.7% | -436.4% | -283.2% | -221.9% | |
| ROIC | 21.2% | 24.4% | 20.3% | 0.09% | 1.4% | -33.0% | · | · | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 | 1.3 | 1.8 | 3.0 | 1.8 | |
| Quick Ratio | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 | 1.0 | 1.5 | 2.8 | 1.6 | |
| Debt / Equity | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 | -16.5 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.2 | 1.2 | 4.5 | -39.7 | -14.1 | · | · | · | |
| Interest Coverage | · | · | 2.4 | 2.0 | 0.1 | -2.2 | -2.6 | -8.6 | -406.1 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 0.1 | |
| Inventory Turnover | 8.2 | 8.2 | 10.8 | 9.5 | 12.1 | · | · | 14.9 | 5.5 | |
| Receivables Turnover | 5.3 | 5.8 | 5.3 | 6.3 | 8.7 | 8.3 | 11.0 | 16.5 | 5.7 |
معدلات النمو 6
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.91% | -2.2% | 3.3% | -9.9% | 12.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.05% | -3.1% | 1.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.29% | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.6% | 37.8% | · | · | · | · | · | · | · | |
| Net Income YoY | 2.8% | 40.2% | 1079450.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 2396.3% | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Net Income TTM | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| Market Cap | $300M | $150M | $206M | $174M | $122M | $411M | $343M | $780M | $3.72B | |
| Enterprise Value | $225M | $116M | $210M | $191M | $137M | $416M | · | · | · | |
| P/E | 9.8 | 4.9 | 9.6 | · | -4.2 | -6.8 | · | · | · | |
| P/S | 1.3 | 0.6 | 0.9 | 0.8 | 0.5 | 1.8 | 1.3 | 3.1 | 134.2 | |
| P/B | 2.3 | 1.6 | 3.9 | 8.1 | -49.8 | -69.1 | 19.6 | 22.7 | 69.7 | |
| P / Tangible Book | 3.4 | 3.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 7.2 | 3.8 | 7.6 | -11.0 | 5.9 | 532.1 | 15.3 | -32.4 | -21.5 | |
| P / FCF | 7.2 | 3.9 | 7.7 | -11.0 | 5.9 | · | · | -31.8 | -21.5 | |
| EV / EBITDA | 6.0 | 3.7 | 6.4 | 8.1 | 106.1 | -13.7 | · | · | · | |
| EV / FCF | 5.4 | 3.0 | 7.8 | -12.1 | 6.6 | · | · | · | · | |
| EV / Revenue | 1.0 | 0.5 | 0.9 | 0.8 | 0.5 | 1.8 | · | · | · | |
| Earnings Yield | 10.2% | 20.3% | 10.4% | 0.00% | -23.7% | -14.8% | · | · | · |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $45M | $75M | $54M | $52M | $46M | $59M | $81M | $47M | $44M | $72M | $56M | $55M | $53M | $66M | $57M | |
| Cost of Revenue | $12M | $10M | $23M | $12M | $12M | $11M | $14M | $29M | $11M | $11M | $24M | $13M | $12M | $13M | $17M | $12M | |
| SG&A Expense | $18M | $18M | $18M | $17M | $18M | $18M | $17M | $17M | $25M | $22M | $20M | $23M | $24M | $22M | $25M | $24M | |
| Operating Expenses | $49M | $49M | $58M | $45M | $46M | $42M | $46M | $58M | $49M | $46M | $57M | $48M | $50M | $48M | $56M | $55M | |
| Operating Income | $8M | $-4M | $17M | $10M | $7M | $4M | $13M | $22M | $-2M | $-2M | $15M | $9M | $5M | $4M | $10M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $831.0K | $1M | $977.0K | $1M | $956.0K | $1M | $1M | $1M | $1M | $972.0K | $719.0K | $689.0K | $660.0K | $537.0K | $519.0K | $216.0K | |
| Other Non-op | $9.0K | $130.0K | $143.0K | $115.0K | $410.0K | $359.0K | $268.0K | $347.0K | $156.0K | $91.0K | $641.0K | $74.0K | $86.0K | $-42.0K | $-204.0K | $64.0K | |
| Pretax Income | $8M | $-3M | $17M | $9M | $6M | $3M | $12M | $21M | $-4M | $-5M | $13M | $6M | $2M | $2M | $-5M | $-293.0K | |
| Income Tax | · | · | · | · | · | · | $-7M | $291.0K | $378.0K | $220.0K | $536.0K | $213.0K | $187.0K | $147.0K | $294.0K | $67.0K | |
| Net Income | $8M | $-4M | $13M | $9M | $6M | $3M | $19M | $20M | $-5M | $-5M | $12M | $6M | $2M | $1M | $-6M | $-360.0K | |
| EPS (Basic) | $0.16 | $-0.07 | $0.26 | $0.18 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.26 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| EPS (Diluted) | $0.16 | $-0.07 | $0.26 | $0.17 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.25 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| Shares (Basic) | 50,939,946 | 50,845,130 | -99,623,885 | 50,339,456 | 49,700,217 | 49,595,697 | -96,841,433 | 49,008,464 | 48,292,414 | 48,189,256 | -93,781,152 | 47,520,338 | 46,759,062 | 46,636,083 | -88,159,871 | 45,567,739 | |
| Shares (Diluted) | 52,596,589 | 50,845,130 | -100,327,655 | 50,929,893 | 50,144,704 | 49,906,341 | -96,554,598 | 49,173,361 | 48,292,414 | 48,189,256 | -94,627,471 | 47,819,234 | 47,201,185 | 47,157,904 | -88,204,189 | 45,567,739 | |
| EBITDA | $8M | $-4M | · | $10M | $7M | · | · | $22M | $-2M | $-2M | · | $9M | $5M | $4M | · | $2M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $36M | $30M | $54M | $55M | $63M | $69M | $67M | $67M | $77M | · | $82M | $60M | $61M | · | $78M | |
| Short-term Investments | $57M | $65M | $68M | $41M | $41M | $30M | $32M | $29M | $30M | $30M | · | $3M | $14M | $10M | · | $0 | |
| Receivables | $34M | $26M | $54M | $34M | $26M | $25M | $32M | $55M | $28M | $25M | · | $29M | $31M | $31M | · | $28M | |
| Inventory | $13M | $9M | $6M | $9M | $9M | $9M | $9M | $3M | $9M | $7M | · | $6M | $8M | $4M | · | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $4M | $5M | $6M | $3M | $3M | $4M | · | $4M | $5M | $5M | · | $7M | |
| Other Current Assets | $199.0K | $196.0K | $256.0K | $230.0K | $73.0K | $98.0K | $91.0K | $236.0K | $241.0K | $255.0K | · | $2M | $573.0K | $449.0K | · | $4M | |
| Current Assets | $145M | $142M | $163M | $144M | $137M | $133M | $148M | $157M | $138M | $143M | · | $125M | $119M | $112M | · | $122M | |
| PP&E (Net) | $103.0K | $124.0K | $187.0K | $305.0K | $388.0K | $474.0K | $515.0K | $601.0K | $680.0K | $757.0K | · | $907.0K | $977.0K | $1M | · | $1M | |
| PP&E (Gross) | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $7M | |
| Intangibles | · | · | $41M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $5M | $6M | $6M | $8M | $14M | $9M | · | $5M | $8M | $9M | · | $15M | |
| Accrued Liabilities | $45M | $38M | $50M | $37M | $32M | $27M | $37M | $51M | $39M | $38M | · | $34M | $35M | $34M | · | $40M | |
| Current Liabilities | $50M | $60M | $81M | $83M | $79M | $87M | $96M | $110M | $104M | $98M | · | $67M | $60M | $48M | · | $60M | |
| Capital Leases | $4M | $5M | $5M | $5M | $0 | $0 | $1M | $3M | $4M | $6M | · | $8M | $10M | $11M | · | $13M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $121.0K | $121.0K | $121.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $54M | $64M | $86M | $88M | $90M | $99M | $121M | $150M | $156M | $163M | · | $165M | $170M | $170M | · | $177M | |
| Long-term Debt | $0 | $11M | $23M | $34M | $45M | $57M | $67M | $79M | $91M | $102M | · | $102M | $102M | $102M | · | $102M | |
| Total Debt | $0 | $11M | · | $34M | $45M | · | · | $78M | $89M | $100M | · | $99M | $99M | $99M | · | $98M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Retained Earnings | $-1.28B | $-1.29B | $-1.28B | $-1.30B | $-1.31B | $-1.31B | $-1.31B | $-1.33B | $-1.35B | $-1.35B | · | $-1.36B | $-1.36B | $-1.37B | · | $-1.36B | |
| AOCI | $-45.0K | $-31.0K | $36.0K | $19.0K | $-14.0K | $-11.0K | $6.0K | $26.0K | $-32.0K | $-26.0K | · | $-4.0K | $-6.0K | · | · | $0 | |
| Stockholders' Equity | $139M | $128M | $130M | $115M | $105M | $97M | $92M | $71M | $49M | $51M | $53M | $39M | $30M | $26M | $22M | $22M | |
| Liabilities + Equity | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Shares Outstanding | 51,102,687 | 50,879,204 | 50,408,023 | 50,384,274 | 49,892,725 | 49,615,174 | 49,105,834 | 49,067,348 | 48,460,120 | 48,214,663 | 47,646,787 | 47,542,790 | 46,947,153 | 46,663,599 | 46,345,660 | 45,608,814 |
التدفق النقدي 9
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $2M | $15M | $14M | $10M | $14M | $4M | $16M | $11M | $1M | $11M | $10M | $11M | $3M | $3M | $8M | $17M | |
| CapEx | $0 | $0 | $-36.0K | $26.0K | $20.0K | $61.0K | $16.0K | $20.0K | $20.0K | $0 | $45.0K | $27.0K | · | · | $0 | $0 | |
| Investing Cash Flow | $8M | $2M | $-27M | $506.0K | $-11M | $2M | $-2M | $259.0K | $703.0K | $-19M | $-8M | $11M | $-5M | $-17M | $-12M | $8M | |
| Financing Cash Flow | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $0 | $0 | $0 | $0 | $0 | $2M | $-53.0K | |
| Net Change in Cash | $-2M | $7M | $-24M | $-1M | $-8M | $-6M | $2M | $114.0K | $-10M | $-8M | $2M | $22M | $-1M | $-15M | $-2M | $25M | |
| Free Cash Flow | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| Net Margin | 14.5% | -8.4% | · | 16.2% | 11.2% | · | · | 25.2% | -9.6% | -11.0% | · | 10.3% | 3.9% | 2.6% | · | -0.63% | |
| Pretax Margin | 14.6% | -7.6% | · | 17.0% | 11.8% | · | · | 25.6% | -8.8% | -10.5% | · | 10.7% | 4.2% | 2.9% | · | -0.51% | |
| EBITDA Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| ROA | 4.2% | -1.9% | · | 4.2% | 2.9% | · | · | 9.6% | -2.2% | -2.4% | · | 2.9% | 1.1% | 0.71% | · | -0.17% | |
| ROE | 6.7% | -3.3% | · | 9.5% | 7.6% | · | · | 37.0% | -11.5% | -12.5% | · | 19.0% | 8.5% | 8.5% | · | -6.4% | |
| ROIC | · | · | · | · | · | · | · | 14.6% | -1.7% | -1.6% | · | 6.0% | 3.5% | 3.2% | · | 2.5% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.4 | · | 1.7 | 1.7 | · | · | 1.4 | 1.3 | 1.5 | · | 1.9 | 2.0 | 2.3 | · | 2.0 | |
| Quick Ratio | 2.6 | 2.1 | · | 1.5 | 1.5 | · | · | 1.4 | 1.2 | 1.3 | · | 1.7 | 1.8 | 2.1 | · | 1.8 | |
| Debt / Equity | 0.0 | 0.1 | · | 0.3 | 0.4 | · | · | 1.1 | 1.8 | 2.0 | · | 2.6 | 3.3 | 3.8 | · | 4.4 | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.1 | · | · | 0.5 | 0.9 | 1.1 | · | 2.0 | 2.9 | 3.8 | · | 4.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -0.7 | · | 2.6 | 1.5 | 1.3 | · | 0.8 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.3 | · | · | 0.4 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.1 | 1.2 | · | 2.0 | 1.4 | · | · | 7.0 | 1.3 | 2.0 | · | 2.4 | 1.7 | 2.4 | · | 2.0 | |
| Receivables Turnover | 1.9 | 1.7 | · | 1.2 | 1.9 | · | · | 1.9 | 1.6 | 1.6 | · | 2.0 | 1.7 | 1.8 | · | 2.2 |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $208M | $198M | · | $233M | $226M | $217M | · | $228M | $202M | $207M | · | $221M | $224M | $215M | · | $209M | |
| Net Income TTM | $19M | $14M | · | $38M | $25M | $14M | · | $17M | $-1M | $5M | · | $9M | $13M | $7M | · | $-39M | |
| Market Cap | $414M | $325M | · | $268M | $171M | · | · | $125M | $158M | $256M | · | $125M | $166M | $144M | · | $108M | |
| Enterprise Value | $321M | $235M | · | $207M | $120M | · | · | $106M | $150M | $248M | · | $139M | $190M | $172M | · | $128M | |
| P/E | 21.3 | 22.8 | · | 7.0 | 6.9 | 10.6 | · | 7.5 | -163.0 | 53.0 | · | 13.8 | 12.6 | 20.6 | · | -2.4 | |
| P/S | 2.0 | 1.6 | · | 1.1 | 0.8 | · | · | 0.6 | 0.8 | 1.2 | · | 0.6 | 0.7 | 0.7 | · | 0.5 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 1.6 | · | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Tangible Book | 3.0 | 2.5 | · | 2.3 | 1.6 | 1.5 | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Cash Flow | · | 21.1 | · | · | · | · | · | · | · | 22.7 | · | · | · | 54.6 | · | · | |
| P / FCF | · | 21.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 42.3 | -61.4 | · | 21.6 | 18.1 | · | · | 4.8 | -68.9 | -108.0 | · | 16.2 | 38.9 | 39.3 | · | 53.5 | |
| EV / FCF | · | 15.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1.5 | 1.2 | · | 0.9 | 0.5 | · | · | 0.5 | 0.7 | 1.2 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | |
| Earnings Yield | 4.7% | 4.4% | · | 14.3% | 14.6% | 9.5% | · | 13.3% | -0.61% | 1.9% | · | 7.2% | 7.9% | 4.9% | · | -40.9% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $228M | $230M | $236M | $228M | $253M |
| هامش الربح التشغيلي % | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% |
| صافي الدخل | $31M | $30M | $22M | $2.0K | $-29M |
| EPS المخفف | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 |
| النسبة الحالية | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 |
| النسبة السريعة | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $42M | $39M | $27M | $-16M | $21M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 174 مقدمي إقرار · $239.8M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 28 (+2 مقابل الربع السابق) | 15 (-2 مقابل الربع السابق) | 56 (+1 مقابل الربع السابق) | 47 (+7 مقابل الربع السابق) | +4.1M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | $33504835 | 4131299 | 13,97% | الأسهم |
| VANGUARD GROUP INC | $21011306 | 3531312 | 8,76% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $18815168 | 2319996 | 7,85% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $14891687 | 1836213 | 6,21% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $14887065 | 1835643 | 6,21% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14805608 | 1825599 | 6,18% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $11407283 | 1406570 | 4,76% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $9618136 | 1185702 | 4,01% | الأسهم |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $9113880 | 1123783 | 3,80% | الأسهم |
| STATE STREET CORP | $7722058 | 952165 | 3,22% | الأسهم |
| KENNEDY CAPITAL MANAGEMENT LLC | $7082082 | 873253 | 2,95% | الأسهم |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $6420006 | 791616 | 2,68% | الأسهم |
| RITHOLTZ WEALTH MANAGEMENT | $6080862 | 749798 | 2,54% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $5214292 | 642946 | 2,17% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $4884166 | 602240 | 2,04% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4318170 | 532450 | 1,80% | الأسهم |
| GLOBEFLEX CAPITAL L P | $3104565 | 382807 | 1,29% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2506850 | 309106 | 1,05% | الأسهم |
| D. E. Shaw & Co., Inc. | $2300377 | 283647 | 0,96% | الأسهم |
| Russell Investments Group, Ltd. | $2207323 | 272173 | 0,92% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $2182158 | 269070 | 0,91% | الأسهم |
| FEDERATED HERMES, INC. | $2033712 | 250766 | 0,85% | الأسهم |
| Empowered Funds, LLC | $1786763 | 220316 | 0,75% | الأسهم |
| PANAGORA ASSET MANAGEMENT INC | $1764290 | 217545 | 0,74% | الأسهم |
| GOLDMAN SACHS GROUP INC | $1758256 | 216801 | 0,73% | الأسهم |
| FMR LLC | $1708274 | 210638 | 0,71% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $1600095 | 197299 | 0,67% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $1526562 | 188232 | 0,64% | الأسهم |
| Prospera Financial Services Inc | $1287530 | 158762 | 0,54% | الأسهم |
| Haven Private, LLC | $1203913 | 148448 | 0,50% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $1140161 | 140587 | 0,48% | الأسهم |
| BlackRock, Inc. | $1134784 | 139924 | 0,47% | الأسهم |
| FIRST TRUST ADVISORS LP | $1055970 | 130206 | 0,44% | الأسهم |
| Bank of New York Mellon Corp | $1048964 | 129342 | 0,44% | الأسهم |
| Round Rock Advisors LLC | $1045476 | 128912 | 0,44% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1040051 | 128243 | 0,43% | الأسهم |
| STRS OHIO | $686106 | 84600 | 0,29% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $596085 | 73500 | 0,25% | الأسهم |
| Trexquant Investment LP | $585729 | 72223 | 0,24% | الأسهم |
| Vise Technologies, Inc. | $584163 | 72030 | 0,24% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $520662 | 64200 | 0,22% | عقد خيار الشراء |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $497000 | 61255 | 0,21% | الأسهم |
| OpenArc Corporate Advisory, LLC | $482472 | 59491 | 0,20% | الأسهم |
| RHUMBLINE ADVISERS | $466397 | 57510 | 0,19% | الأسهم |
| TWO SIGMA ADVISERS, LP | $423045 | 71100 | 0,18% | الأسهم |
| D'Orazio & Associates, Inc. | $394795 | 48680 | 0,16% | الأسهم |
| Vanguard Global Advisers, LLC | $375225 | 46267 | 0,16% | الأسهم |
| DEUTSCHE BANK AG\ | $350287 | 43192 | 0,15% | الأسهم |
| Man Group plc | $336614 | 41506 | 0,14% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $333240 | 41090 | 0,14% | الأسهم |
| WINTON GROUP Ltd | $328528 | 40509 | 0,14% | الأسهم |
| XTX Topco Ltd | $326801 | 40296 | 0,14% | الأسهم |
| State of Wyoming | $323046 | 39833 | 0,13% | الأسهم |
| WELLS FARGO & COMPANY/MN | $304977 | 37605 | 0,13% | الأسهم |
| EntryPoint Capital, LLC | $303200 | 37386 | 0,13% | الأسهم |
| Baron Wealth Management LLC | $294977 | 36372 | 0,12% | الأسهم |
| Creative Planning | $289827 | 35737 | 0,12% | الأسهم |
| LPL Financial LLC | $280095 | 34537 | 0,12% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $279673 | 34485 | 0,12% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $257468 | 31747 | 0,11% | الأسهم |
| Kathmere Capital Management, LLC | $252805 | 31172 | 0,11% | الأسهم |
| FRANKLIN RESOURCES INC | $242165 | 29860 | 0,10% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $236731 | 29190 | 0,10% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $212660 | 26222 | 0,09% | الأسهم |
| MARTINGALE ASSET MANAGEMENT L P | $205703 | 25364 | 0,09% | الأسهم |
| Metis Global Partners, LLC | $204891 | 25264 | 0,09% | الأسهم |
| MetLife Investment Management, LLC | $201720 | 24873 | 0,08% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195451 | 24100 | 0,08% | عقد خيار البيع |
| C2C Wealth Management, LLC | $191558 | 23620 | 0,08% | الأسهم |
| Nuveen, LLC | $187982 | 23179 | 0,08% | الأسهم |
| PRELUDE CAPITAL MANAGEMENT, LLC | $174754 | 21548 | 0,07% | الأسهم |
| One Wealth Advisors, LLC | $170951 | 21079 | 0,07% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $165306 | 20383 | 0,07% | الأسهم |
| CITIGROUP INC | $154990 | 19111 | 0,06% | الأسهم |
| BAILARD, INC. | $146791 | 18100 | 0,06% | الأسهم |
| Invesco Ltd. | $142493 | 17570 | 0,06% | الأسهم |
| JANE STREET GROUP, LLC | $141925 | 17500 | 0,06% | عقد خيار الشراء |
| Spark Investment Management LLC | $137870 | 17000 | 0,06% | الأسهم |
| MORGAN STANLEY | $137416 | 16944 | 0,06% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $136490 | 21360 | 0,06% | الأسهم |
| Brandywine Global Investment Management, LLC | $129710 | 21800 | 0,05% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $127481 | 15719 | 0,05% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $125510 | 15476 | 0,05% | الأسهم |
| Lido Advisors, LLC | $122015 | 15045 | 0,05% | الأسهم |
| Mariner, LLC | $120593 | 14869 | 0,05% | الأسهم |
| Caprock Group, LLC | $112421 | 13862 | 0,05% | الأسهم |
| PERKINS CAPITAL MANAGEMENT INC | $108674 | 13400 | 0,05% | الأسهم |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $107960 | 13312 | 0,05% | الأسهم |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $105624 | 13203 | 0,04% | الأسهم |
| UBS Group AG | $99923 | 12321 | 0,04% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $97774 | 12056 | 0,04% | الأسهم |
| CWM, LLC | $97531 | 15263 | 0,04% | الأسهم |
| R Squared Ltd | $97247 | 11991 | 0,04% | الأسهم |
| Abel Hall, LLC | $93427 | 11520 | 0,04% | الأسهم |
| IEQ CAPITAL, LLC | $86542 | 10671 | 0,04% | الأسهم |
| Williams & Novak, LLC | $85066 | 10489 | 0,04% | الأسهم |
| Vanguard Personalized Indexing Management, LLC | $84409 | 10408 | 0,04% | الأسهم |
| Ethic Inc. | $83290 | 10270 | 0,03% | الأسهم |
| AQR CAPITAL MANAGEMENT LLC | $83136 | 10251 | 0,03% | الأسهم |
| INTECH INVESTMENT MANAGEMENT LLC | $82803 | 10210 | 0,03% | الأسهم |
المطلعون على الشركة 24 من المطلعين · مسؤولون 10 · مديرون 12
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Alan H Auerbach | President and CEO | 6 يوليو، 2026 S | 7261671 | 0 | 1 | $-363919 |
| Maximo F Nougues | Chief Financial Officer | 6 يوليو، 2026 S | 230637 | 0 | 1 | $-77528 |
| Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | 6 يوليو، 2026 S | 196841 | 0 | 1 | $-69880 |
| Alvin F Wong | Chief Scientific Officer | 17 يونيو، 2021 A | — | 0 | 0 | $0 |
| Richard Paul Bryce | Title of Reporting Person: Chief Medical and Scientific Officer | 5 إبريل، 2021 S | 121662 | 0 | 0 | $0 |
| Jeffrey Jerome Ludwig | Chief Commercial Officer | 17 فبراير، 2021 A | 36069 | 0 | 0 | $0 |
| Steven Lo | Chief Commercial Officer | 22 يوليو، 2019 S | 19557 | 0 | 0 | $0 |
| Charles R Eyler | Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer | 4 فبراير، 2019 S | 31957 | 0 | 0 | $0 |
| Robert Charnas | The Reporting Person is the Senior Vice President of Regulatory Affairs and Project Management of the Issuer. | 16 فبراير، 2017 A | 26453 | 0 | 0 | $0 |
| Richard Benton Phillips | The Reporting Person is the Interim Head of Regulatory Affairs, Quality Assurance and Pharmacovigilance of the Issuer. | 15 إبريل، 2016 A | — | 0 | 0 | $0 |
| Brian M Stuglik | مدير | 12 يونيو، 2026 S | 113858 | 0 | 1 | $-58320 |
| Allison Dorval | مدير | 12 يونيو، 2026 S | 90780 | 0 | 1 | $-83592 |
| Adrian Senderowicz | مدير | 12 يونيو، 2026 S | 27000 | 0 | 1 | $-194400 |
| Troy Edward Wilson | مدير | 12 يونيو، 2026 S | 59750 | 0 | 1 | $-77760 |
| Jay M Moyes | مدير | 12 يونيو، 2026 S | 58322 | 0 | 1 | $-158840 |
| Alessandra Cesano | مدير | 11 يونيو، 2026 A | 68850 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | مدير | 11 يونيو، 2026 A | 81000 | 0 | 0 | $0 |
| Ann Calby Miller | مدير | 15 يونيو، 2021 A | 40732 | 0 | 0 | $0 |
| Hugh O'Dowd | مدير | 9 يونيو، 2020 A | 25748 | 0 | 0 | $0 |
| Frank Zavrl | مدير | 9 يونيو، 2020 A | 50993 | 0 | 0 | $0 |
| Thomas Malley | مدير | 15 ديسمبر، 2014 A | 156551 | 0 | 0 | $0 |
| Faraaz Siddiqi | — | 4 أكتوبر، 2011 D | 0 | 0 | 0 | $0 |
| Kapil Munjal | — | 4 أكتوبر، 2011 D | 0 | 0 | 0 | $0 |
| Robert Andrew Johnson | — | 4 أكتوبر، 2011 D | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 7 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Alan H. Auerbach ×6 إيداعات | 13 ديسمبر، 2022 | — | إيداع أولي | استثمار سلبي | SEC |
| Kapil Munjal 2) | 4 أكتوبر، 2011 | — | إيداع أولي | — | SEC |
| Faraaz Siddiqi 2) | 4 أكتوبر، 2011 | — | إيداع أولي | — | SEC |
| Robert Johnson 2) | 4 أكتوبر، 2011 | — | إيداع أولي | — | SEC |
| Robert Johnson | 21 نوفمبر، 2007 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه | 19 نوفمبر، 2007 | — | إيداع أولي | — | SEC |
| Faraaz Siddiqi | 19 نوفمبر، 2007 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 36 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0,72% | 52608 NS | 30 إبريل، 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,46% | 233908 SH | 8 أغسطس، 2026 | يومي |
| IWC · iShares Trust | 0,08% | 150797 SH | 8 أغسطس، 2026 | يومي |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 34260 SH | 8 أغسطس، 2026 | يومي |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,05% | 1924360 NS | 31 مايو، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 55680 NS | 31 مايو، 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 2746 SH | 8 أغسطس، 2026 | يومي |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 95559 NS | 31 مايو، 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 32358 SH | 8 أغسطس، 2026 | يومي |
| IWN · iShares Trust | 0,02% | 356623 SH | 8 أغسطس، 2026 | يومي |
| BIB · ProShares Trust | 0,02% | 1879 NS | 31 مايو، 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 55064 SH | 8 أغسطس، 2026 | يومي |
| IWM · iShares Trust | 0,01% | 1153241 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,01% | 19123 NS | 30 إبريل، 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,01% | 16014 SH | 8 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 254380 SH | 8 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,01% | 166672 NS | 30 إبريل، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 156761 NS | 30 إبريل، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 82003 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2027 NS | 31 مايو، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3611 NS | 30 إبريل، 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,01% | 5394 NS | 31 مايو، 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1585 NS | 31 مايو، 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 65370 SH | 8 أغسطس، 2026 | يومي |
| URTY · ProShares Trust | 0,00% | 1603 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2071 NS | 31 مايو، 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 34919 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6348 NS | 30 إبريل، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 مايو، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9704 NS | 30 إبريل، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 15090 NS | 30 إبريل، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 12376 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 446899 SH | 8 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1343121 SH | 8 أغسطس، 2026 | يومي |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7680 SH | 8 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2979 SH | 8 أغسطس، 2026 | يومي |